Onconano

Developer of a compound that exploits pH as a biomarker to diagnose and treat cancer

placeSouthlake, Texas, United States calendar_todayFounded 2014 groups20 employees language onconano.com

Registered entities

Social engagement

Social engagement: 2.2K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Advantech Capital, state.tx.us.

Investor typeCountShare
Venture capital343%
Bank & private debt114%
Other / undisclosed343%

Recent activity

6 May 2026
Event
26th Biopharma Drug Discovery Nexus Conference
17 Apr 2026
Event
AACR2026
Coming soon